VAISHALI PHARMA LIMITED·Healthcare Companies·Pharmaceuticals & Biotechnology Companies

2026-08-21 NSE Web 10% Result 14 Aug

Price

7.99

+0.5%
O:7.95
H:8.19
L:7.76
C:7.99

52W Range

4.7512.76
+68%/-37%

Market Cap

₹104.24 Cr

Traded: ₹0.06 Cr (0.06%) 0.0x

Free Float: ₹52.98 Cr (0.11% of FF traded)

Volume · 60D trend

76.12 K 0.0x

Delivery: % 0.0x

View Delivery Data

Returns

1W:+0% 1M:+9% 3M:+5% 6M:+4% 12M:+1%

Valuation

P/E23.5
P/B1.5
P/S1.0
EV/EBIT260598109.2

Business Strength

ROE6.0%
ROCE--
OPM3.7%
NPM3.7%

Growth (3Y CAGR)

EPS--
Sales--
Profit--
3Y Return-14.0%

Balance Sheet

Debt/Equity0.3
Debt18.54 Cr
Pledge0.0%
CWIP/Fixed Asset0.0%

Cash Position

CFO/NP--
FCF--
FCF 3Y Avg--
Cash/MCap--

Others

Div Yield0.0%
Div Payout0.0%
Cash Conv. Cycle102 days
Tradeable Free Float50.8%

MTF Exposure Trend

60 sessions · funded amount, % of FF, daily delta

Current
₹ 85.67 L
1.62% FF
60d high
₹ 1.59 Cr
60d low
₹ 0
60d mean
₹ 1.44 Cr
vs mean
▼ 40.58%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
Sales
--
--
--
--
--
--
Profit
--
--
--
--
--
--
Return
--
+17.0%
-14.0%
-30.0%
--
Decelerating
ROE
--
--
--
--
--
--

Quarterly Results

Jun 2026

14 Aug
Rev
23 Cr
----
OPM6.5%
NPM--
PAT
--2 Cr
EPS
--0.1

Mar 2026

1 Jun
Rev
27 Cr
--+9% QoQ
OPM-0.7%
NPM1.5%
PAT
--0 Cr
EPS
--0.0

Dec 2025

14 Feb
Rev
25 Cr
---26% QoQ
OPM6.3%
NPM5.3%
PAT
--1 Cr
EPS
--0.1

Sep 2025

PDF
Rev
33 Cr
----
OPM4.2%
NPM3.6%
PAT
--1 Cr
EPS
--0.1

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity0.28
Interest Coverage--x
Promoter Pledge0.0%
Borrowings19 Cr

Efficiency

Receivable Days170 days
Inventory Days13 days
Payable Days81 days
Cash Conversion cycle102 days

Cash Position

Operating Cash Flow--
Investing Cash Flow--
Financing Cash Flow--
Free Cash Flow--

Detailed Financials

Jun 2026PDF ↗
Mar 2026PDF ↗
Dec 2025PDF ↗
Sep 2025PDF ↗
Sales23272533
Expenses21272332
Operating Profit1-021
OPM %6.5%-0.7%6.3%4.2%
Other Income1111
Interest0110
Depreciation0000
Profit Before Tax2022
Tax %13.9%-61.1%28.2%28.3%
Net Profit2011
Exceptional Items--------
EPS (Rs)0.10.00.10.1
Sales Growth (YoY)--------
Sales Growth (QoQ)--9.3%-26.3%--
OP Growth (YoY)--------
OP Growth (QoQ)845.0%-112.8%12.2%--
Profit Growth (YoY)--------
EPS Growth (YoY)--------
EPS Growth (QoQ)---70.0%11.1%--
OP Margin---0.7%6.3%4.2%
Net Margin--1.5%5.3%3.6%
Material Cost %85.0%91.0%85.0%89.0%
Employee Cost %3.0%3.0%3.0%2.0%
P/S0.97------
P/E23.50------
P/B1.511.61----

Shareholding Pattern

Shareholders:26.7K (+184.7%)
Current MixJul 2026

Annual Reports

6

2025

2024

2023

2022

2021

2020

Concalls

4

Feb 2024

29 Feb 2024

Nov 2023

30 Nov 2023

Aug 2020

31 Aug 2020

May 2020

31 May 2020